Top

Journal of Neuro-Oncology

Published in:

01-09-2008 | Invited Manuscript

Neuroradiological assessment of newly diagnosed glioblastoma

Authors: Srini Mukundan, Chad Holder, Jeffrey J. Olson

Published in: Journal of Neuro-Oncology | Issue 3/2008

Excerpt

Level I:

Whenever possible, it is recommended that magnetic resonance imaging with the addition of gadolinium contrast enhancement be used because it provides information that may allow differentiation of glioblastoma from other intrinsic tumors and secondary tumors.

…

Landis JR, Kock GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174PubMedCrossRef

Walters BC (1998) Clinical practice parameter development in neurosurgery. In: Bean J (ed) Neurosurgery in transition: the socioeconomic transformation of neurological surgery. Williams and Wilkins, Baltimore, pp 99–111

Amundsen P, Dugstad G, Syvertsen AH (1978) The reliability of computer tomography of the diagnosis and differential diagnosis of meningiomas, gliomas and brain metastases. Acta Neurochir 41:177–190CrossRef

Dadparvar S, Krishna L, Miyamoto C et al (1994) Indium-111-labeled anti-EGFr-425 scintigraphy in the detection of malignant gliomas. Cancer 73:884–889PubMedCrossRef

Prat-Acin R, Diaz-Vicente FJ, Banzo-Marraco J et al (1997) Histological prediction of cerebral tumors using SPECT with ²⁰¹Tl. Rev Neurol 25:1168–1170PubMed

Oriuchi N, Tamura M, Shibazaki T et al (1991) Evaluation of ²⁰¹Tl SPECT in patients with glioma: a comparative study with histological diagnosis, clinical feature and proliferative activity. Japanese Journal of Nuclear Medicine 28:1263–1271PubMed

Taki S, Kakuda K, Kakuma K (1999) 201Tl SPET in the differential of brain tumours. Nucl Med Commun 20:637–645PubMedCrossRef

Dean BL, Drayer BP, Bird CR et al (1990) Gliomas: classification with MR imaging. Radiology 174:411–415PubMed

Sugahara T, Korogi Y, Kochi M et al (1998) Correlation of MR imaging—determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. Am J Radiol 171:1479–1486

10.

Lev MH, Ozsunar Y, Henson JW, Rasheed AA et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. Am J Neuroradiol 25:214–221PubMed

11.

Ketonen L (1978) Computerized tomography for diagnosis of supratentorial tumors. Acta Neurol Scand Suppl 67:153–164PubMed

12.

Choksey MS, Valentine A, Shawdon H et al (1989) Computed tomography in the diagnosis of malignant brain tumours: do all patients require biopsy? J Neurol Neurosurg Psychiatr 52:821–825PubMed

13.

Katano H, Karasawa K, Sugiyama N et al (2002) Comparison of thallium-201 uptake and retention indices for evaluation of brain lesions with SPECT. J Clin Neurosci 9:653–658PubMedCrossRef

14.

Black KL, Emerick T, Hoh C et al (1994) Thallium-201 SPECT and positron tomography equal predictors of gliomas grade and recurrence. Neurol Res 16:93–96PubMed

15.

Igase K, Oka Y, Ohta S et al (2002) Usefulness of thallium-201 single photon emission computed tomography to quantify the malignancy grade of brain tumors. Neurol Med Chir (Tokyo) 36:434–439CrossRef

16.

Baillet G, Albuquerque L, Chen Q et al (1994) Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21:1061–1066PubMedCrossRef

17.

Sjoholm H, Elmqvist D, Rehncrona S et al (1995) SPECT imaging of gliomas with thallium-201 and technetium-99m-HMPAO. Acta Neurol Scand 91:66–70PubMed

18.

Reimann B, Papke K, Hoess N et al (2002) Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-l-α-methyltyrosine SPECT. Radiology 225:567–574CrossRef

19.

Debelke D, Meyerowitz C, Lapidus RL et al (1995) Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47–52

20.

Bell D, Grant R, Collie D et al (2002) How well do radiologists diagnose intracerebral tumor histology on CT? Findings from a prospective multicentre study. Br J Neurosurg 16:573–577PubMed

21.

Negendank WG, Sauter R, Brown TR et al (1996) Magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84:449–458PubMed

22.

Carapella CM, Carpinelli G, Knijn A et al (1997) Potential role of in vitro ¹H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumors. Acta Neurochir Suppl 68:127–132PubMed

23.

Tamiya T, Kinoshita K, Ono Y et al (2000) Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 42:333–338PubMedCrossRef

24.

Howe FA, Barton SJ, Cudlip SA et al (2003) Metabolic profiles of human brain tumors using quantitative in vivo magnetic resonance 1H spectroscopy. Magn Reson Med 49:223–232PubMedCrossRef

25.

Moller-Hartmann W, Herminghaus S, Krings T et al (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381PubMedCrossRef

26.

Lee SJ, Kim JH, Kim YM et al (2001) Perfusion MR imaging in gliomas: comparison with histologic grade. Korean J Radiol 2:1–7PubMedCrossRef

27.

Shin JH, Lee HK, Kwun BD et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas. Am J Radiol 179:783–789

28.

Roberts HC, Roberts TPL, Bollen AW et al (2001) Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grad and tumor labeling index: a study in human brain tumors. Acad Radiol 8:384–391PubMedCrossRef

29.

Beppu T, Inoue T, Shibata Y et al (2003) Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neuro-oncol 63:109–116CrossRef

30.

Kurki T, Lundbom N, Kalimo H et al (1995) MR Classification of brain gliomas: value of magnetization transfer and conventional imaging. Magn Reson Imaging 13:501–511PubMedCrossRef

31.

Uematsu H, Maeda M, Sadato N et al (2002) Measurement of the vascularity and vascular leakage of gliomas by double-echo dynamic magnetic resonance imaging. A preliminary study. Invest Radiol 37:571–576PubMedCrossRef

32.

Murphy M, Loosemore A, Clifton AG et al (2002) The contribution of proton magnetic resonance spectroscopy (¹HMRS) to clinical brain tumour diagnosis. Br J Neurosurg 16:329–334PubMedCrossRef

33.

Murphy PS, Rowland IJ, Viviers L et al (2003) Could assessment of glioma methylene lipid resonance by in vivo ¹H-MRS be of clinical value? Br J Radiol 76:459–463PubMedCrossRef

34.

Isobe T, Matsumura A, Anno I et al (2002) Quantification of cerebral metabolites in gliomas patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 20:343–349PubMedCrossRef

35.

Poptani H, Kaartinen J, Gupta RK et al (1999) Diagnostic assessment of brain tumors and non-neoplastic brain disorders in vivo using proton nuclear magnetic resonance spectroscopy and artificial neural networks. J Cancer Res Clin Oncol 125:343–349PubMedCrossRef

36.

Rutter A, Hugenholtz H, Saunders JK et al (1995) One-dimensional phosphorus-31 chemical shift imaging of human brain tumors. Invest Radiol 30:359–366PubMedCrossRef

37.

Sugahara T, Korogi Y, Kochi M (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60PubMedCrossRef

38.

Castillo M, Smith JK, Kwock L et al (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22:60–64PubMed

39.

Lam WWM, Poon WS, Metreweli C (2002) Diffusion MR imaging in glioma: does it have any role n the pre-operation determination of grading glioma? Clin Radiol 57:219–225PubMedCrossRef

Title: Neuroradiological assessment of newly diagnosed glioblastoma
Authors: Srini Mukundan
Chad Holder
Jeffrey J. Olson
Publication date: 01-09-2008
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2008
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-008-9616-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neuroradiological assessment of newly diagnosed glioblastoma

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2008

Diagnosis of malignant glioma: role of neuropathology

Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults

Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme

The emergence of clinical practice parameter guidelines in neuro-oncology: promise of utility tempered with caution

Guidelines for the treatment of newly diagnosed glioblastoma: introduction

Surgical management of newly diagnosed glioblastoma in adults: role of cytoreductive surgery